Literature DB >> 18629574

Classification and categorisation of psoriatic arthritis.

Laura C Coates, Philip S Helliwell.   

Abstract

For over 30 years, investigators have used the simple but non-validated classification criteria suggested by Moll and Wright. Several authors have suggested modifications to these but most remain unvalidated or require human leukocyte antigen analysis. Now, a worldwide initiative has developed new criteria which include both clinical and radiological features. These will require further study before they are fully adopted but their improved performance should result in less variation between study cohorts. The recurring question of disease heterogeneity continues to occupy researchers in this field. Despite recent pleas to abandon the original five sub-groups, a case can be made for retaining at least the two sub-groups of peripheral and axial disease and, possibly, splitting the peripheral disease into oligo- and poly-arthritis.

Entities:  

Mesh:

Year:  2008        PMID: 18629574     DOI: 10.1007/s10067-008-0947-4

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  37 in total

1.  Prospective two year follow up study comparing novel and conventional imaging procedures in patients with arthritic finger joints.

Authors:  M Backhaus; G R Burmester; D Sandrock; D Loreck; D Hess; A Scholz; S Blind; B Hamm; M Bollow
Journal:  Ann Rheum Dis       Date:  2002-10       Impact factor: 19.103

2.  Proposed classification criteria of psoriatic arthritis. A preliminary study in 260 patients.

Authors:  B Fournié; L Crognier; C Arnaud; L Zabraniecki; V Lascaux-Lefebvre; V Marc; E Ginesty; V Andrieu; C Dromer; A Fournié
Journal:  Rev Rhum Engl Ed       Date:  1999-10

3.  Psoriasis and psoriatic arthritis. Dermatological and rheumatological co-operative clinical report.

Authors:  C Biondi Oriente; R Scarpa; A Pucino; P Oriente
Journal:  Acta Derm Venereol Suppl (Stockh)       Date:  1989

4.  Clinical and radiological changes during psoriatic arthritis disease progression.

Authors:  Mustafa Khan; Catherine Schentag; Dafna D Gladman
Journal:  J Rheumatol       Date:  2003-05       Impact factor: 4.666

5.  Mortality studies in psoriatic arthritis: results from a single outpatient center. II. Prognostic indicators for death.

Authors:  D D Gladman; V T Farewell; K Wong; J Husted
Journal:  Arthritis Rheum       Date:  1998-06

6.  The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy.

Authors:  M Dougados; S van der Linden; R Juhlin; B Huitfeldt; B Amor; A Calin; A Cats; B Dijkmans; I Olivieri; G Pasero
Journal:  Arthritis Rheum       Date:  1991-10

7.  Psoriatic arthritis (PSA)--an analysis of 220 patients.

Authors:  D D Gladman; R Shuckett; M L Russell; J C Thorne; R K Schachter
Journal:  Q J Med       Date:  1987-02

8.  Psoriatic arthritis: outcome of disease subsets and relationship of joint disease to nail and skin disease.

Authors:  S M Jones; J B Armas; M G Cohen; C R Lovell; G Evison; N J McHugh
Journal:  Br J Rheumatol       Date:  1994-09

9.  Death rates and causes of death in patients with rheumatoid arthritis: a population-based study.

Authors:  S Sihvonen; M Korpela; P Laippala; J Mustonen; A Pasternack
Journal:  Scand J Rheumatol       Date:  2004       Impact factor: 3.641

10.  The Influence of the HLA-DRB1 rheumatoid arthritis shared epitope on the clinical characteristics and radiological outcome of psoriatic arthritis.

Authors:  Eleanor Korendowych; Jonathan Dixey; Beverly Cox; Sharon Jones; Neil McHugh
Journal:  J Rheumatol       Date:  2003-01       Impact factor: 4.666

View more
  7 in total

1.  Which clinical variables have the most significant correlation with quality of life evaluated by SF-36 survey in Croatian cohort of patient with ankylosing spondylitis and psoriatic arthritis?

Authors:  Zrinka Jajić; Ivana Rajnpreht; Nataša Kovačić; Ivan Krešimir Lukić; Vedran Velagić; Frane Grubišić; Ana Marušić; Danka Grčević
Journal:  Rheumatol Int       Date:  2011-11-08       Impact factor: 2.631

2.  Classification criteria for spondyloarthropathies.

Authors:  Ozgur Akgul; Salih Ozgocmen
Journal:  World J Orthop       Date:  2011-12-18

3.  Sharing Patient and Clinician Experiences of Moderate-to-Severe Psoriasis: A Nationwide Italian Survey and Expert Opinion to Explore Barriers Impacting upon Patient Wellbeing.

Authors:  Francesca Prignano; Alexandra M G Brunasso; Gabriella Fabbrocini; Giuseppe Argenziano; Federico Bardazzi; Riccardo G Borroni; Martina Burlando; Anna Elisabetta Cagni; Elena Campione; Elisa Cinotti; Aldo Cuccia; Stefano Dastoli; Rocco De Pasquale; Clara De Simone; Vito Di Lernia; Valentina Dini; Maria Concetta Fargnoli; Elisa Faure; Alfredo Giacchetti; Claudia Giofrè; Giampiero Girolomoni; Claudia Lasagni; Serena Lembo; Francesco Loconsole; Maria Antonia Montesu; Paolo Pella; Paolo Pigatto; Antonio Giovanni Richetta; Elena Stroppiana; Marina Venturini; Leonardo Zichichi; Stefano Piaserico
Journal:  J Clin Med       Date:  2022-05-16       Impact factor: 4.964

4.  Management of psoriatic arthritis in rheumatology and dermatology settings: sub-analysis of the Italian population from the international LOOP study.

Authors:  Ennio Lubrano; Andrea Delle Sedie; Marco Romanelli; Maria Sole Chimenti; Luca Bianchi; Stefano Piaserico; Catia De Felice; Dario Graceffa; Maria Ilenia De Andres; Salvatore Curatolo; Rosa Daniela Grembiale; Stefano Dastoli; Chiara Arcuri; Rosa Giuseppa Angileri; Francesca Prignano; Francesca Bandinelli; Elena Baldissera; Santo Raffaele Mercuri; Chiara Franchi; Matteo Longhi; Angela Patrì; Francesco Caso; Giuseppe Passiu; Maria Antonia Montesu; Simone Parisi; Elena Stroppiana; Genoveffa Scotto di Luzio; Giovanni Italiano; Sergio Di Nuzzo; Daniele Santilli; Laura Bigi; Federica Lumetti; Concetto Paolo Agnusdei; Maria Grazia Ferrucci; Giuliana Gualberti; Francesca Marando; Roberta Ramonda; Francesco Cusano
Journal:  Clin Rheumatol       Date:  2020-11-06       Impact factor: 2.980

5.  Prediction and benefits of minimal disease activity in patients with psoriatic arthritis and active skin disease in the ADEPT trial.

Authors:  Philip J Mease; Arthur Kavanaugh; Laura C Coates; Iain B McInnes; Maja Hojnik; Ying Zhang; Jaclyn K Anderson; Alexander P Dorr; Dafna D Gladman
Journal:  RMD Open       Date:  2017-07-18

6.  Juvenile Psoriatic Arthritis (JPsA): juvenile arthritis with psoriasis?

Authors:  Yonatan Butbul Aviel; Pascal Tyrrell; Rayfel Schneider; Sandeep Dhillon; Brian M Feldman; Ronald Laxer; Rotraud K Saurenmann; Lynn Spiegel; Bonnie Cameron; Shirley Ml Tse; Earl Silverman
Journal:  Pediatr Rheumatol Online J       Date:  2013-03-15       Impact factor: 3.054

7.  Clinical Specialty Setting as Determinant of Management of Psoriatic Arthritis: A Cross-Sectional Brazilian Study.

Authors:  Cacilda da Silva Souza; Cláudia Goldenstein-Schainberg; Sonia Maria Alvarenga Anti Loduca Lima; Natali Spelling Gormezano; Renata Ferreira Magalhães; Roberto Ranza
Journal:  J Clin Rheumatol       Date:  2022-04-01       Impact factor: 3.517

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.